Autres langues Ipsen

Actions

IPN

FR0010259150

Produits pharmaceutiques

Marché Fermé - Euronext Paris 17:55:00 30/07/2026 Après clôture 18:38:54
157,20 EUR -3,97% Graphique intraday de Ipsen 157,30 +0,06%

Autres langues

18:00 Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
15:49 IPSEN : Another quarterly beat; 2026 guidance upgraded
09:40 Ipsen S.A. Reports Earnings Results for the Half Year Ended June 30, 2026
07:32 Ipsen Raises FY26 Sales Growth Outlook
07:00 Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance
29/07 Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07 Ipsen Announces Appointment of Catherine Bradley, CBE, as an Independent Director, Chair of the Audit Committee and Member of the Compensation Committee, Effective July 29, 2026
27/07 IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026
24/07 Healthcare Shares Benefit From Rotation Away From AI Darlings -- Health Care Roundup
24/07 Ipsen Provides Update On Phase III BOLD Trial In Biliary Atresia
24/07 Ipsen Says Phase 3 Trial of Bylvay in Biliary Atresia Misses Primary Endpoint
24/07 Ipsen provides update on Phase III BOLD trial in biliary atresia
22/07 Ipsen Closes Purchase of Potravitug Developer Memo Therapeutics
22/07 Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
22/07 Ipsen S.A. acquired Memo Therapeutics AG.
21/07 IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2026
15/07 IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
14/07 Where would AI lead Pharma in the long run?
13/07 Ipsen : IQIRVO® demonstrates statistically significant improvement in ALP normalization in patients with PBC in Phase IIIb ELSPIRE study
10/07 Ipsen - Dysport is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine
09/07 Afternoon Meeting: Wall Street ignora las alarmas
09/07 Wall Street Ignores the Sirens
09/07 Ipsen Reports Positive Topline Phase III Results for Dysport in Both Episodic and Chronic Migraine
09/07 Öl hält die Märkte in Atem
09/07 Oil keeps markets on edge
Aucun résultat pour cette recherche